Collecting biological samples and imaging data to study heart health and disease
Official title: Molecular and Imaging Studies of Cardiovascular Health and Disease
Run by National Heart Centre Singapore · NCT02804269 · Data updated 2026-11-12
This study is collecting health information and samples from people with heart conditions and healthy volunteers to learn more about heart health and disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years to 90 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | National Heart Centre Singapore Academic / other |
| Locations | 1 site (Singapore, Singapore) |
| Status | Recruiting |
| Started | July 2013 |
| Main results expected | July 2033 |
| Study ends | July 2033 |
| Registry record updated | June 17, 2016 |
| Trial ID | NCT02804269 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged between 16 and 90 years, including both patients with cardiovascular conditions and healthy volunteers.
✕Probably not a fit
Patients outside the age range of 16 to 90 years will not be eligible to participate in this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program gathers biological samples, health information, and imaging data from participants at the National Heart Centre Singapore. It aims to study various cardiovascular conditions, including dilated cardiomyopathy, hypertrophic cardiomyopathy, and ischemic heart disease, by comparing data from both patients and healthy volunteers. The collected biospecimens will be stored indefinitely for future research on molecular and imaging aspects of cardiovascular health. The study employs cardiovascular magnetic resonance imaging and fat mass measurement as part of its methodology.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of cardiovascular diseases and lead to improved diagnostic and treatment strategies.
How similar studies have gone: Other studies utilizing biobanks and imaging techniques have shown promise in advancing cardiovascular research, indicating that this approach is both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
There is no inclusion/exclusion criteria except for the age limit as this is a repository program. Inclusion Criteria: •Subject aged ≥ 16 years and ≤ 90 years. Exclusion Criteria: •No
Where it's running
-
National Heart Centre Singapore
Singapore, Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Stuart Cook, MBBS,PhD — National Heart Centre Singapore
- Study coordinator: Siew Ching Kong
- Email: kong.siew.ching@nhcs.com.sg
- Phone: (65) 67042275
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based assessment of heart function using ECG wearable monitors
This study tests if a new AI tool using a wearable heart monitor can accurately check heart function in people with heart failure compared to traditional heart scans.
-
Observing the causes and progression of cardiomyopathy
This study is trying to understand what causes cardiomyopathy and how it gets worse by collecting DNA, blood samples, and health information from people with the condition or those at risk.
-
A quick 10-minute heart scan for cardiac diseases
This study is testing a quick 10-minute heart scan to see if it can help diagnose heart problems better and faster for many patients without needing special dyes.
-
Analyzing genetic mutations in pediatric cardiomyopathy
This study is trying to learn more about the genetic causes of heart problems in children with cardiomyopathy to help improve diagnosis and treatment options for them.
-
Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease
This study tests whether an outpatient cardiac telerehabilitation program can be as safe and effective as conventional rehab for people with ischemic heart disease.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.